Accès ouvert
2025
article
OpenAlex
Francisco Ujueta, Gervasio A. Lamas, Kevin J. Anstrom, Ana Navas‐Acién et autres
Importance: In 2013, the Trial to Assess Chelation Therapy (TACT) reported that in 1708 patients with stable coronary disease and prior myocardial infarction (MI), oral multivitamins and multiminerals (OMVMs), in a factorial design with edetate disodium (EDTA) chelation therapy, did not reduce …
us, ca
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Gervasio A. Lamas, Kevin J. Anstrom, Ana Navas‐Acién, Robin Boineau et autres
Importance: In 2013, the Trial to Assess Chelation Therapy (TACT) reported that edetate disodium (EDTA)-based chelation significantly reduced cardiovascular disease (CVD) events by 18% in 1708 patients with a prior myocardial infarction (MI). Objective: To replicate the finding of TACT in individuals …
us, ca
(code pays fourni par la source)
2015
article
OpenAlex
Arthur J. Berkson, Claudio Perez-Ledezma, Bishnu Rauth
us
(code pays fourni par la source)
Accès ouvert
2009
article
OpenAlex
Burton M. Berkson, Daniel Rubin, Arthur J. Berkson
The authors, in a previous article, described the long-term survival of a man with pancreatic cancer and metastases to the liver, treated with intravenous alpha-lipoic acid and oral low-dose naltrexone (ALA/N) without any adverse effects. He is alive and well 78 months …
us
(code pays fourni par la source)
Accès ouvert
2007
article
OpenAlex
Burton M. Berkson, Daniel Rubin, Arthur J. Berkson
T.M. is a 61-year-old man with a medical history significant for type 2 diabetes mellitus, rheumatoid arthritis, hypothyroidism, and hyperlipidemia. For these, he had been prescribed (via physicians other than the authors) levothyroxine, metformin, glyburide, and fenofibrate. Regarding the diagnosis of follicular …
us
(code pays fourni par la source)
Accès ouvert
2006
article
OpenAlex
Burton M. Berkson, Daniel Rubin, Arthur J. Berkson
The authors describe the long-term survival of a patient with pancreatic cancer without any toxic adverse effects. The treatment regimen includes the intravenous alpha-lipoic acid and low-dose naltrexone (ALA-N) protocol and a healthy lifestyle program. The patient was told by a reputable …
us
(code pays fourni par la source)